These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21228496)

  • 1. Serum cytokeratin 18 M30 antigen level and its correlation with nutritional parameters in middle-aged Japanese males with nonalcoholic fatty liver disease (NAFLD).
    Tabuchi M; Tomioka K; Kawakami T; Murakami Y; Hiramatsu M; Itoshima T; Sugawara S; Kawashima A; Okita M; Tsukamoto I
    J Nutr Sci Vitaminol (Tokyo); 2010; 56(5):271-8. PubMed ID: 21228496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of Serum Phospholipid n-6 Polyunsaturated Fatty Acid Compositions in Nonalcoholic Fatty Liver Disease in the Japanese Population: A Cross-Sectional Study.
    Jiang Z; Hayashi T; Kashima K; Kurotani K; Shirouchi B; Mizoue T; Sato M
    Lipids; 2020 Nov; 55(6):599-614. PubMed ID: 32691411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
    Chan WK; Sthaneshwar P; Nik Mustapha NR; Mahadeva S
    PLoS One; 2014; 9(9):e105903. PubMed ID: 25184298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.
    Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Aker S; Yilmaztepe A; Gurel S; Gulten M; Nak SG
    World J Gastroenterol; 2007 Feb; 13(6):837-44. PubMed ID: 17352011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease.
    Liang J; Han T; Gao YT; Jing L; Ma Z
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China.
    Zheng JS; Xu A; Huang T; Yu X; Li D
    Lipids; 2012 Jun; 47(6):549-56. PubMed ID: 22527845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Serum Dihomo-γ-linolenic Acid Levels Are Associated with Obesity, Body Fat Accumulation, and Insulin Resistance in Japanese Patients with Type 2 Diabetes.
    Tsurutani Y; Inoue K; Sugisawa C; Saito J; Omura M; Nishikawa T
    Intern Med; 2018 Oct; 57(20):2929-2935. PubMed ID: 29877283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.
    Tsutsui M; Tanaka N; Kawakubo M; Sheena Y; Horiuchi A; Komatsu M; Nagaya T; Joshita S; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Aoyama T; Tanaka E; Sano K
    J Clin Gastroenterol; 2010 Jul; 44(6):440-7. PubMed ID: 20104187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CK 18-M30 reflect liver pathological severity during NAFLD progression in a rat model.
    Xue L; Lu X; He J; Zhang T; Wu X; Zhang Y; Wang N; An Z; Xu J; Geng Y
    Pathol Res Pract; 2018 Nov; 214(11):1778-1786. PubMed ID: 30149902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.
    Zheng KI; Liu WY; Pan XY; Ma HL; Zhu PW; Wu XX; Targher G; Byrne C; Wang XD; Chen YP; Lu F; Zheng MH
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32139603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.
    Cao W; Zhao C; Shen C; Wang Y
    PLoS One; 2013; 8(12):e82092. PubMed ID: 24324749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light alcohol consumption plays a protective role against non-alcoholic fatty liver disease in Japanese men with metabolic syndrome.
    Sogabe M; Okahisa T; Taniguchi T; Tomonari T; Tanaka T; Tanaka H; Nakasono M; Takayama T
    Liver Int; 2015 Jun; 35(6):1707-14. PubMed ID: 25438866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Cytokeratin-18 Level As a Novel Biomarker for Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Mandelia C; Collyer E; Mansoor S; Lopez R; Lappe S; Nobili V; Alkhouri N
    J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):181-7. PubMed ID: 26835904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease frequency and associated factors at admission of acute stroke.
    Mori T; Yoshioka K; Tanno Y
    Hepatol Int; 2022 Feb; 16(1):81-88. PubMed ID: 34524608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum Ck18-M65 and M30 levels in patients with chronic hepatitis B combined with nonalcoholic steatohepatitis and liver fibrosis.
    Dai L; Yan Y; Chen Q
    Medicine (Baltimore); 2024 Jun; 103(23):e38342. PubMed ID: 38847670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between liver injury and serum cytokeratin 18 levels in asymptomatic hepatitis B virus carriers and in patients with chronic hepatitis B infection.
    Balkan A; Yılmaz N; Balkan Y; Koruk I; Örkmez M; Aydınlı M; Koruk M
    Arab J Gastroenterol; 2017 Jun; 18(2):98-103. PubMed ID: 28579343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease.
    Vos MB; Barve S; Joshi-Barve S; Carew JD; Whitington PF; McClain CJ
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):481-5. PubMed ID: 18852641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.
    Shen J; Chan HL; Wong GL; Chan AW; Choi PC; Chan HY; Chim AM; Yeung DK; Yu J; Chu WC; Wong VW
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1057-66. PubMed ID: 23066946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.